Analysts upgrade Tenet shares — 4 quick facts


 Vet analysts upgraded Tenet shares from a “hold” rating to a “buy” rating, according to MidSouth News & Analysis.

Advertisement

Here are four quick facts:

1. Vet has a $34.02 price target on Tenet stock.

2. On Nov. 13, Glenview Capital Management major shareholder bought 900,000 Tenet shares for a total transaction of nearly $29 million.

3. Tenet has a 50-day moving average of $33.74 and a 200-day moving average of $46.88.

4. The market cap is $3.21 billion.

Click here to read more about Tenet’s Q3 financial report. 

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.